Will Ozempic bankrupt the U.S. healthcare system? : comparem

Providing GLP-1 drugs to 19.7 million Medicare beneficiaries with obesity would cost $268 billion a year, researchers estimate in a recent study.

Related Keywords

Vermont , United States , Boston , Massachusetts , Houston , Texas , Denmark , Germany , United Kingdom , Danish , Americans , Lauren Eberly , Brad Wenstrupr Ohio , Bernie Sanders , John Cawley , Eli Lilly , Caroline Apovian , Phillip Swagel , Eli Lilly Mounjaro , Lawrence Gostin , Donna Cooper , Davidj Phillip , Georgetown University , Novo Nordisk , Drug Administration , Human Services , Pensions Committee , Senate Health , Yale School Of Medicine , Medicaid Services , University Of Pennsylvania , Sander Senate , Centers For Medicare , Congressional Budget Office , Us Department Of Health , New England Journal , Melissa Barber , Yale School , Brad Wenstrup , Reduce Obesity Act , Weight Management , Inflation Reduction Act ,